According to the 2022 WHO classification, clinically nonfunctional pituitary adenomas include SF1‐lineage tumors, silent TPIT‐lineage tumors, null cell tumors, and some PIT1‐lineage tumors. This evidence concerns the gene TBX19 and pituitary gland adenoma.